Clinical Outcomes Following Median Arcuate Ligament Release in Patients Responsive to Celiac Plexus Block.
Median arcuate ligament release
Median arcuate ligament syndrome
celiac plexus block
Journal
Journal of vascular and interventional radiology : JVIR
ISSN: 1535-7732
Titre abrégé: J Vasc Interv Radiol
Pays: United States
ID NLM: 9203369
Informations de publication
Date de publication:
03 Jan 2024
03 Jan 2024
Historique:
received:
26
05
2023
revised:
04
12
2023
accepted:
27
12
2023
medline:
6
1
2024
pubmed:
6
1
2024
entrez:
5
1
2024
Statut:
aheadofprint
Résumé
To determine if symptom relief with celiac plexus block (CPB) was associated with favorable clinical outcomes after median arcuate ligament release (MALR) surgery. A retrospective review was performed from January 2000 to December 2021. Fifty-seven patients (42 females, 15 males; mean age 43 years (range:18-84years)), with clinical and radiographic features suggestive of median arcuate ligament syndrome (MALS), underwent CT-guided percutaneous celiac plexus block for suspected MALS. Clinical outcomes of celiac plexus block and median arcuate ligament surgery were correlated. Adverse events were classified according to the SIR guidelines. CT-guided percutaneous celiac plexus block was successfully performed in all 57 (100%) patients with suspected MALS. A cohort of 38 (67%) patients had clinical improvement with celiac plexus block. A subset of 28 (74%) patients of this group subsequently underwent open median arcuate release surgery. 27 (96%) respondents to CPB had favorable clinical outcome with surgery. There was one (4 %) celiac plexus block related mild adverse event. There were no moderate, severe, or life-threatening adverse events. Patients who responded to CPB were selected to undergo surgery, and 96% of them improved.
Identifiants
pubmed: 38181971
pii: S1051-0443(23)01465-3
doi: 10.1016/j.jvir.2023.12.569
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © 2024. Published by Elsevier Inc.